United States global health policy: HIV/AIDS, maternal and child health, and The President's Emergency Plan for AIDS Relief (PEPFAR)
Increased plasmacytoid dendritic cell maturation and natural killer cell activation in HIV-1 exposed, uninfected intravenous drug users
Activation of Notch signaling pathway in HIV-associated nephropathy
HIV-1 subtype B and C integrase enzymes exhibit differential patterns of resistance to integrase inhibitors in biochemical assays
Dual-tropic HIV type 1 isolates vary dramatically in their utilization of CCR5 and CXCR4 coreceptors
Poor immunogenicity of the H1N1 2009 vaccine in well controlled HIV-infected individuals
Pharmacokinetics and virologic response of zidovudine/lopinavir/ritonavir initiated during the third trimester of pregnancy
Associations of antiretroviral drug use and HIV-specific risk factors with carotid intima–media thickness
Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: a phase 2 placebo-controlled ANRS trial
A randomized controlled trial of intermittent compared with daily cotrimoxazole preventive therapy in HIV-infected children
High prevalence of reduced bone mineral density in primary HIV-1-infected men
Immunodeficiency and renal impairment are risk factors for HIV-associated acute renal failure
Kaposi sarcoma herpes virus antibody response and viremia following highly active antiretroviral therapy in the Swiss HIV Cohort study
Prevention of invasive pneumococcal disease among HIV-infected adults in the era of childhood pneumococcal immunization
Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002–2007
No evidence of increased sexual risk behaviour after initiating antiretroviral therapy among people who inject drugs
Reconstitution of immune responses against Kaposi sarcoma-associated herpesvirus
Preventing influenza coinfection among HIV-infected persons: a complex picture coming into focus
Virosomal influenza-vaccine induced immunity in HIV-infected individuals with high versus low CD4+ T-cell counts: clues towards a rational vaccination strategy
HIV acquisition is associated with prior high-risk human papillomavirus infection among high-risk women in Rwanda
Pandemic flu: a comparative evaluation of clinical, laboratory, and radiographic findings in HIV-positive and negative children
Dizygotic twins discordant for HIV-1 despite vertical transmission prophylaxis: was human leukocyte antigen homozygosity of disadvantage to the infected twin?
Deleterious pharmacokinetic interaction between bexarotene and efavirenz
Ethics and the standards of prevention in HIV prevention trials
Response to ‘Ethics and the standards of prevention in HIV prevention trials’